Literature DB >> 16020821

Outcomes of patients in a low-intensity, short-duration involuntary outpatient commitment program.

David A Pollack1, Bentson H McFarland, Jo M Mahler, Anne E Kovas.   

Abstract

This study examined the outcomes of patients in a low-intensity, short-duration involuntary outpatient commitment program. After release from inpatient commitment, one group (N = 150) entered an involuntary outpatient commitment program that lasted up to six months; a comparison group (N = 140) was released into the community without further involuntary care. After the analysis adjusted for confounding variables, patients who were in the involuntary outpatient commitment program had greater use of follow-up outpatient and residential services and psychotropic medications than patients in the comparison group. No differences were found between the groups in follow-up acute psychiatric hospitalization or arrests. Low-intensity, short-duration involuntary outpatient commitment appears to have a limited, but important, impact.

Entities:  

Mesh:

Year:  2005        PMID: 16020821     DOI: 10.1176/appi.ps.56.7.863

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  3 in total

Review 1.  Protecting Health and Safety with Needed-Treatment: the Effectiveness of Outpatient Commitment.

Authors:  Steven P Segal
Journal:  Psychiatr Q       Date:  2021-01-06

Review 2.  Impact of involuntary out-patient commitment on reducing hospital services: 2-year follow-up.

Authors:  Laura Castells-Aulet; Miguel Hernández-Viadel; Jesús Jiménez-Martos; Carlos Cañete-Nicolás; Carmen Bellido-Rodríguez; Roman Calabuig-Crespo; Pedro Asensio-Pascual; Guillem Lera-Calatayud
Journal:  BJPsych Bull       Date:  2015-08

3.  Compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness: a systematic review and meta-analysis.

Authors:  Phoebe Barnett; Hannah Matthews; Brynmor Lloyd-Evans; Euan Mackay; Stephen Pilling; Sonia Johnson
Journal:  Lancet Psychiatry       Date:  2018-11-01       Impact factor: 27.083

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.